In our previous investigations, we could demonstrate that extract preparati
ons of Hypericum perforatum (St. John's wort, SJW) inhibit the uptake of se
veral neurotransmitters (serotonin, norepinephrine, dopamine, GABA, L-gluta
mate) in synaptosomal preparations of rodent brain. Hyperforin, the lipophi
lic constituent, was identified as the main component responsible for these
effects. The properties seen for hyperforin in these and other pharmacolog
ical models present a plausible and logical explanation for the well docume
nted antidepressive effects of SJW extract preparations in clinical studies
. However, evidence for other active principles in SJW extract have been re
ported [2,3] (See also communications by Misane & Ogren and Philippu in thi
s issue). Accordingly, we tested various SJW extract preparations and all r
elevant constituents as possible inhibitors of synaptosomal uptake of neuro
transmitters. Two further components were found to be active in those model
s. Adhyperforin, like hyperforin, showed a strong inhibiting profile in all
uptake systems investigated. Moreover, we could observe a weak to moderate
inhibiting profile for the oligomeric procyanidins fraction (OPC). Further
investigations would have to clarify any possible contribution of these tw
o constituents to the antidepressive effects of SJW extract seen in animal
experiments and clinical trials.